How do I buy Labcorp Holdings Inc. (LH) stock?

Buying Labcorp Holdings Inc. (LH) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "LH", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy LH by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if LH is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Labcorp Holdings Inc. (LH) Stock

Q: What is the minimum investment for LH on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Labcorp Holdings Inc. from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · LH

Trade LH

Key stats

Market cap: $30.23B
Price / Earnings ratio: 30.0x
EPS (TTM): $12.27
Volume: Loading
52-week high: $373.76
52-week low: $245.00
Dividend yield: 0.77%
Dividend amount (latest): $0.72
EPS vs analyst estimate: +1.2%Q3 FY25 · $4.18 vs $4.13

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with LH

Technical indicators

RSI 14: 71.66
MACD 12/26/9: 13.87
EMA 9 of MACD: 11.78
MACD histogram: 2.10
SMA 50: $328.04; Price above SMA 50
EMA 50: $333.71; Price above EMA 50
SMA 200: $291.38; Price above SMA 200
EMA 200: $296.64; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 4 analyst ratings

Strong Sell0

Sell0

Hold1

Buy3

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

17B11B6B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

24B16B8B0

Revenue to Profit

2025

$14.0B

Revenue

$0.0

Cost of revenue

$4.0B

Gross profit

$0.0

Operating expenses

$876.5M

Net income

Earnings

EPS forecast

Actual EPS

$3.84

$4.17

Q1FY25

$4.35

$4.15

Q2FY25

$4.18

$4.13

Q3FY25

$3.94

Q4FY25

$4.10

Q1FY26

The market is expecting earnings per share of $4.10 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Labcorp Holdings Inc.

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and save lives.

SectorHealthcare

IndustryDiagnostics & Research

Employees71,000

CEOMr. Adam H. Schechter

IPO DateMar 29, 1990

HeadquartersBurlington, NC

Key Executives

Name	Title	Year Born
Mr. Adam H. Schechter	President, CEO & Chairman	1965
Dr. Brian J. Caveney J.D., M.D., M.P.H.	Exec VP, President of Biopharma Laboratory Services & Chief Medical and Scientific Officer	1974
Mr. Peter J. Wilkinson	Senior VP & Chief Accounting Officer	1971
Mr. Akinbolade Oyegunwa M.B.A., Ph.D.	Executive VP and Chief Information & Technology Officer	1983
Mr. Dewey Steadman C.F.A.	Senior Vice President of Investor Relations	—
Ms. Anita Z. Graham	Executive VP & Chief Human Resources Officer	1971
Dr. Marcia T. Eisenberg Ph.D.	Enterprise Chief Scientific Officer & Senior VP	1959

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											+0.0	+10.1
2022	-9.0	-0.6	-2.0	-8.7	+1.5	-4.6	+8.8	-12.7	-9.8	+4.7	+8.2	-2.6
2023	+6.0	-4.3	-3.6	-1.6	-7.5	+13.6	+2.4	-2.6	-2.7	+0.1	+6.4	+3.8
2024	-4.4	-3.8	+0.2	-6.9	-3.2	+4.4	+6.1	-1.5	-2.7	+4.1	+6.2	-4.7
2025	+9.5	+1.3	-8.4	+3.6	+3.2	+5.9	-1.6	+6.3	+4.9	-9.0	+4.2	-6.3
2026	+7.9	+7.0	-6.9	-5.8	+1.6	+9.0	+8.9	+8.2	-6.0	+18.6	+4.7

Stocks in the same sector

Thermo Fisher Scientific

FAQ

Buying Labcorp Holdings Inc. (LH) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "LH", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy LH by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Labcorp Holdings Inc. from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Yes, Labcorp Holdings Inc. regularly pays dividends to shareholders. Currently, the estimated dividend yield for LH is around 0.77% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Labcorp Holdings Inc. (LH) Stock

Key stats

Compare with LH

Recent news

Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?

Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?

LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm

LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm

Labcorp Q3 Earnings Call Highlights

Labcorp Q3 Earnings Call Highlights

LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up

LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?

Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?

LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm

LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm

Labcorp Q3 Earnings Call Highlights

Labcorp Q3 Earnings Call Highlights

LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up

LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up

Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics

Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics

Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates

Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates

Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests

Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests

LH vs. DHR: Which Stock Is the Better Value Option?

LH vs. DHR: Which Stock Is the Better Value Option?

Labcorp Prepares to Report Q3 Earnings: What's in the Cards?

Labcorp Prepares to Report Q3 Earnings: What's in the Cards?

OPKO Health to Sell Select BioReference Assets to Labcorp for $722M

OPKO Health to Sell Select BioReference Assets to Labcorp for $722M

About Labcorp Holdings Inc.

Key Executives

Fundamentals

Valuation

Profitability

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade